| Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease (NCT02700919) | Mereo BioPharma | 2016-08-01 |
| Telemedical Training for Chronically Ill COPD Patients: a Cross Sectoral Study (NCT02754232) | Odense University Hospital | 2016-08-01 |
| Understanding Patient Management of COPD Exacerbations (NCT02725294) | VA Puget Sound Health Care System | 2016-08-01 |
| Corticosteroid Reduction in COPD (NCT02857842) | Chronic Obstructive Pulmonary Disease Trial Network, Denmark | 2016-08-01 |
| Personalized Prediction Strategy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (NCT03240315) | Guangzhou Institute of Respiratory Disease | 2016-08-01 |
| An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients (NCT02799784) | GlaxoSmithKline | 2016-07-14 |
| Right Heart Dysfunction and Pulmonary Hypertension Evaluation in Airway Disease Using Cardiac Magnetic Resonance (NCT02865577) | University of Leicester | 2016-07-02 |
| The Cohort Study for Chronic Obstructive Pulmonary Disease (COPD) in China (NCT03044847) | Beijing Chao Yang Hospital | 2016-07-01 |
| Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT02729051) | GlaxoSmithKline | 2016-06-29 |
| Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT02786927) | GlaxoSmithKline | 2016-06-21 |
| A Study Comparing the Closed Triple Therapy, Open Triple Therapy and a Dual Therapy for Effect on Lung Function in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT02731846) | GlaxoSmithKline | 2016-06-01 |
| A 24 Week Efficacy Study of Inhaled Umeclidinium (UMEC) in Patients of Chronic Obstructive Pulmonary Disease (COPD) Using a Novel Dry Powder Inhaler (NDPI) (NCT02184611) | GlaxoSmithKline | 2016-05-09 |
| Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (NCT02587351) | University of Minnesota | 2016-05-01 |
| New Technology to Assess Treatment for Chronic Obstructive Pulmonary Disease (COPD) (NCT02826343) | University of Virginia | 2016-05-01 |
| Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease) (NCT02719184) | Boehringer Ingelheim | 2016-04-13 |
| Modified Dantien Salee Yoga Training Program in Chronic Obstructive Pulmonary Disease Rehabilitation (NCT02770677) | Mahidol University | 2016-04-07 |
| Innate Immunity in Ozone-induced Airway Inflammation in COPD (NCT04669743) | University of California, San Francisco | 2016-04-07 |
| OTIVACTO Regional Center Vienna (RCV) Non-Interventional Study (NIS) (NCT02719639) | Boehringer Ingelheim | 2016-04-01 |
| Spot Marching Exercise Test in Chronic Obstructive Pulmonary Disease (NCT02719457) | Khon Kaen University | 2016-04-01 |
| Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK2269557 Administered Via the ELLIPTA Dry Powder Inhaler to Healthy Subjects (NCT02691325) | GlaxoSmithKline | 2016-03-14 |
| Fixed Dose Combination Versus Free Combination of Tiotropium and Olodaterol in COPD (NCT02683109) | Boehringer Ingelheim | 2016-03-08 |
| Respiratory Microbiome and COPD Exacerbations (RESMECOPD) (NCT03432234) | Corporacion Parc Tauli | 2016-03-07 |
| Home Balance Pilot for Fall Reduction in COPD (NCT02695342) | McMaster University | 2016-03-01 |
| Pragmatic Trial of Video Education in Nursing Homes (NCT02612688) | Brown University | 2016-03-01 |
| Effect of Magnesium Supplementation in COPD (NCT02680769) | University of Padova | 2016-03-01 |
| Erythrocytes Membrane Stability in COPD Patients in Long-Term Home Oxygen Therapy (NCT02732444) | Federal University of Uberlandia | 2016-03-01 |
| Measurements of Diaphragmatic Mobility on COPD Patients (NCT02838953) | Casa Di Cura Villa Serena SpA | 2016-03-01 |
| COPD Online Rehabilitation (CORe) (NCT02667171) | University Hospital Bispebjerg and Frederiksberg | 2016-03-01 |
| Chronic Obstructive Pulmonary Disease (COPD) Breathing Record Study (NCT02814253) | TidalSense | 2016-02-17 |
| Comparing the Efficacy of Tiotropium + Olodaterol Fixed Dose Combination (FDC) Over Tiotropium in Improvement of Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese COPD Patients (NCT02629965) | Boehringer Ingelheim | 2016-02-12 |
| Dose Escalating Study of CCI15106 Inhalation Capsules in Healthy Subjects and Moderate Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT03243760) | GlaxoSmithKline | 2016-02-10 |
| CHF COPD Sip Feed Anabolic Response (NCT02770092) | Texas A&M University | 2016-02-10 |
| A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects (NCT02663089) | Theravance Biopharma | 2016-02-08 |
| Chronic Obstructive Pulmonary Disorder and Acute Exercise (NCT02780219) | Texas A&M University | 2016-02-04 |
| The Nasal Airway in Chronic Obstructive Pulmonary Disease (NCT02826954) | Norwegian University of Science and Technology | 2016-02-01 |
| GSK961081 Alone and With Fluticasone Furoate (FF), Phase 1 (Ph1), Single Dose Regimen (SD), Repeat Dose Regimen (RD), Pharmacokinetic (PK) Study in Healthy Volunteer (HV) (NCT02666287) | GlaxoSmithKline | 2016-01-27 |
| Safety, Tolerability and Pharmacokinetics and Effect on Inflammation of Oral BI 1026706 in Patients With COPD (NCT02642614) | Boehringer Ingelheim | 2016-01-25 |
| Computed Tomography Assessment of Regional Ventilation (CURVE) (NCT02879773) | Heart of England NHS Trust | 2016-01-22 |
| Feasibility and Effects of KOL-webben in Patients With COPD (NCT02696187) | Umeå University | 2016-01-21 |
| Effects of an Exercise Rehabilitation Programme With a Nasal Inspiratory Restriction Device in COPD Patients (NCT03936348) | University of Cadiz | 2016-01-15 |
| Assessment of Physical Functioning and Handling of Spiolto® Respimat® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice (NCT02675517) | Boehringer Ingelheim | 2016-01-13 |
| Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo (NCT02661438) | Bayer | 2016-01-12 |
| Carbon Dioxide Rebreathing During Exercise Assisted by Non-invasive Ventilation (NCT02655484) | Guangzhou Institute of Respiratory Disease | 2016-01-01 |
| Nutritional Status in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease (NCT03709498) | Evangelismos Hospital | 2016-01-01 |
| SATisfaction and Adherence to COPD Treatment (NCT02689492) | Boehringer Ingelheim | 2015-12-11 |
| Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease (NCT02573870) | GlaxoSmithKline | 2015-12-01 |
| Withdrawal of Inhaled Corticosteroids in Primary Care Patients With COPD (NCT02691988) | Radboud University Medical Center | 2015-12-01 |
| Effect of Expiratory Positive Pressure on Dynamic Hyperinflation and Ability to Exercise With Upper Limbs in COPD (NCT03073564) | Hospital de Clinicas de Porto Alegre | 2015-12-01 |
| Cathelicidin and Vitamin D: Impact on Populations At-Risk and With COPD (NCT02464059) | University of North Carolina, Chapel Hill | 2015-11-10 |
| Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02570165) | GlaxoSmithKline | 2015-11-06 |
| A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute Exacerbation (NCT02522299) | GlaxoSmithKline | 2015-11-04 |
| Inspiratory Muscle Training for Breathless Patients With Chronic Obstructive Pulmonary Disease and Heart Failure (NCT02579200) | Queen's University | 2015-11-01 |
| Inspiratory Muscle Training for Patients With Chronic Obstructive Pulmonary Disorder (NCT02673242) | Sykehuset Innlandet HF | 2015-11-01 |
| A Trial to Study the Effects of Pulmonary Rehabilitation Program on Exercise Capacity and Quality of Life in Patients With Severe Form of Chronic Obstructive Pulmonary Disease (COPD) (NCT02512549) | All India Institute of Medical Sciences | 2015-11-01 |
| Circulating Tumor Cells in Lung Cancer Screening (NCT02500693) | Centre Hospitalier Universitaire de Nice | 2015-10-30 |
| Modulation of Steroid Immunosuppression by Alveolar Efferocytosis (NCT03034642) | VA Ann Arbor Healthcare System | 2015-10-01 |
| Sustaining Training Effects Through Physical Activity (NCT02702791) | KU Leuven | 2015-10-01 |
| Ease of Use and Correct Use Study of Placebo ELLIPTA® Inhaler in COPD Subjects (NCT02586493) | GlaxoSmithKline | 2015-10-01 |
| Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma (NCT02619357) | GlaxoSmithKline | 2015-09-21 |
| Benefits of Liquid Oxygen in COPD Patients Presenting Desaturation During Exercise. (NCT02273830) | Jtarrega | 2015-09-01 |
| Evaluation of the Effect of Roflumilast in Hyperinflated COPD Patients Using Functional Respiratory Imaging (NCT02451540) | FLUIDDA nv | 2015-09-01 |
| ScreenFlow: Strategy for Finding Cases of Moderate-to-Severe COPD (NCT02753556) | Dimagi Inc. | 2015-09-01 |
| MISSION COPD - Modern Innovative SolutionS in Improving Outcomes iN COPD (NCT02534766) | Portsmouth Hospitals NHS Trust | 2015-09-01 |
| Pulmonary Rehab, Dyspnea, Walk and Step Testing in COPD (NCT02542826) | McGill University | 2015-08-01 |
| A Drug Utilisation Post-authorisation Study of New Users of Aclidinium Bromide (Monotherapy or in Combination) (NCT03333018) | AstraZeneca | 2015-07-06 |
| Pharmacokinetics of Co-administration of Seretide 250 Diskus (HCP0910) and Spiriva Capsule for Inhalation (HGP1011) (NCT02441114) | Seoul National University Hospital | 2015-07-01 |
| A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary Disease (NCT02628769) | Imperial College London | 2015-07-01 |
| Effects of N-acetylcysteine on Cardiorespiratory Control in COPD Patients With Mild-to-moderate Airflow Obstruction (NCT02579772) | Queen's University | 2015-07-01 |
| A Psychological Intervention to Promote Acceptance and Adherence to NIV in People With COPD (NCT02499653) | Fondazione Don Carlo Gnocchi ETS | 2015-06-01 |
| Brown Adipose Tissue Activity and Energy Metabolism in Cachexia (NCT02500004) | Maastricht University Medical Center | 2015-06-01 |
| A 5-Period, Single Dose, Phase 1 Study in Healthy Elderly Subjects to Assess Relative Bioavailability and Food Effect of Two Oral Formulations of GSK1325756 (Free Base vs HBr Salt) and Food Effect on the HBr Formulation When Given With Omeprazole (NCT02453022) | GlaxoSmithKline | 2015-05-18 |
| China Chronic Obstructive Pulmonary Disease Registration Research (NCT02929537) | Henan University of Traditional Chinese Medicine | 2015-05-01 |
| Validation of the 1-minute Sit-to-stand Test in Patients With COPD (NCT02441725) | University of Zurich | 2015-04-01 |
| Small Airways Evaluation and Treatment (NCT02526758) | Zhujiang Hospital | 2015-04-01 |
| The Trajectory of Physical Activity Following Pulmonary Rehabilitation (NCT02399254) | Trinity Health Of New England | 2015-04-01 |
| An Efficacy Study of GSK2269557 Added to Standard Care in Subjects With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease (NCT02294734) | GlaxoSmithKline | 2015-03-31 |
| Neutrophil Imaging in Healthy Subjects Following Lipopolysaccharide or Saline Challenge and in Subjects With Chronic Obstructive Pulmonary Disease (NCT02551614) | GlaxoSmithKline | 2015-03-17 |
| Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD (NCT02386735) | Prof. Dr. Jörg Leuppi | 2015-03-01 |
| BENEFITS OF ACLIDINIUM BROMIDE IN THE RELIEF OF COPD SYMPTOMS INCLUDING COUGH (NCT02375724) | AstraZeneca | 2015-03-01 |
| Effect of Intravenous Iron (Ferinject®) on Exercise Capacity and Quality of Life of Stable COPD Patients (NCT02416778) | Georg-Christian Funk | 2015-02-01 |
| A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD) (NCT02275052) | GlaxoSmithKline | 2015-01-23 |
| A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT02345161) | GlaxoSmithKline | 2015-01-23 |
| Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease. (NCT02296138) | Boehringer Ingelheim | 2015-01-13 |
| To Evaluate Effects of GSK2256294 on Pulmonary Artery Pressure in Healthy Volunteers Under Normoxic and Hypoxic Conditions (NCT02262689) | GlaxoSmithKline | 2015-01-08 |
| Resveratrol In Chronic Obstructive Pulmonary Disease (COPD) Patients (CARMENS-trial) (NCT02245932) | Maastricht University Medical Center | 2015-01-01 |
| An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary Disease (NCT02366637) | Pfizer | 2015-01-01 |
| Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD) (NCT02302417) | GlaxoSmithKline | 2015-01-01 |
| Safety and Efficacy Study of Losmapimod (GW856553) in Frequently Exacerbating Participants With Chronic Obstructive Pulmonary Disease (COPD) (NCT02299375) | GlaxoSmithKline | 2014-12-09 |
| Acute Effects of a Stretching Program of the Rib Cage Muscles on Patients With COPD During Exercise (NCT02383277) | Universidade Federal de Pernambuco | 2014-11-01 |
| Low Load, High-repetitive Elastic Band Resistance Training in COPD (NCT02283580) | Laval University | 2014-11-01 |
| Adaptive Non-invasive Ventilation to Abolish Tidal Flow Limitation (NCT04497090) | Politecnico di Milano | 2014-10-23 |
| Smart Textile Sensor System for Health Monitoring (NCT05473702) | Nanowear Inc. | 2014-10-23 |
| Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium (NCT02257385) | GlaxoSmithKline | 2014-10-15 |
| Effect of Traditional Chinese Medicine on Outcomes in Patients With Severe / Very Severe COPD (NCT02270424) | Henan University of Traditional Chinese Medicine | 2014-10-01 |
| A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT02257372) | GlaxoSmithKline | 2014-09-30 |
| A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT02236611) | GlaxoSmithKline | 2014-09-26 |
| The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Have Symptoms on Tiotropium (NCT01899742) | GlaxoSmithKline | 2014-09-15 |
| A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT02152605) | GlaxoSmithKline | 2014-09-01 |
| A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (NCT02207829) | GlaxoSmithKline | 2014-09-01 |
| Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices (NCT02184624) | GlaxoSmithKline | 2014-08-28 |